Cargando…

Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate

The immune system offers several mechanisms of response to harmful microbes that invade the human body. As a first line of defense, neutrophils can remove pathogens by phagocytosis, inactivate them by the release of reactive oxygen species (ROS) or immobilize them by neutrophil extracellular traps (...

Descripción completa

Detalles Bibliográficos
Autores principales: Roach, Dwayne R., Noël, Benoît, Chollet-Martin, Sylvie, de Jode, Mathieu, Granger, Vanessa, Debarbieux, Laurent, de Chaisemartin, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458410/
https://www.ncbi.nlm.nih.gov/pubmed/37632068
http://dx.doi.org/10.3390/v15081726
_version_ 1785097158963232768
author Roach, Dwayne R.
Noël, Benoît
Chollet-Martin, Sylvie
de Jode, Mathieu
Granger, Vanessa
Debarbieux, Laurent
de Chaisemartin, Luc
author_facet Roach, Dwayne R.
Noël, Benoît
Chollet-Martin, Sylvie
de Jode, Mathieu
Granger, Vanessa
Debarbieux, Laurent
de Chaisemartin, Luc
author_sort Roach, Dwayne R.
collection PubMed
description The immune system offers several mechanisms of response to harmful microbes that invade the human body. As a first line of defense, neutrophils can remove pathogens by phagocytosis, inactivate them by the release of reactive oxygen species (ROS) or immobilize them by neutrophil extracellular traps (NETs). Although recent studies have shown that bacteriophages (phages) make up a large portion of human microbiomes and are currently being explored as antibacterial therapeutics, neutrophilic responses to phages are still elusive. Here, we show that exposure of isolated human resting neutrophils to a high concentration of the Pseudomonas phage PAK_P1 led to a 2-fold increase in interleukin-8 (IL-8) secretion. Importantly, phage exposure did not induce neutrophil apoptosis or necrosis and did not further affect activation marker expression, oxidative burst, and NETs formation. Similarly, inflammatory stimuli-activated neutrophil effector responses were unaffected by phage exposure. Our work suggests that phages are unlikely to inadvertently cause excessive neutrophil responses that could damage tissues and worsen disease. Because IL-8 functions as a chemoattractant, directing immune cells to sites of infection and inflammation, phage-stimulated IL-8 production may modulate some host immune responses.
format Online
Article
Text
id pubmed-10458410
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104584102023-08-27 Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate Roach, Dwayne R. Noël, Benoît Chollet-Martin, Sylvie de Jode, Mathieu Granger, Vanessa Debarbieux, Laurent de Chaisemartin, Luc Viruses Brief Report The immune system offers several mechanisms of response to harmful microbes that invade the human body. As a first line of defense, neutrophils can remove pathogens by phagocytosis, inactivate them by the release of reactive oxygen species (ROS) or immobilize them by neutrophil extracellular traps (NETs). Although recent studies have shown that bacteriophages (phages) make up a large portion of human microbiomes and are currently being explored as antibacterial therapeutics, neutrophilic responses to phages are still elusive. Here, we show that exposure of isolated human resting neutrophils to a high concentration of the Pseudomonas phage PAK_P1 led to a 2-fold increase in interleukin-8 (IL-8) secretion. Importantly, phage exposure did not induce neutrophil apoptosis or necrosis and did not further affect activation marker expression, oxidative burst, and NETs formation. Similarly, inflammatory stimuli-activated neutrophil effector responses were unaffected by phage exposure. Our work suggests that phages are unlikely to inadvertently cause excessive neutrophil responses that could damage tissues and worsen disease. Because IL-8 functions as a chemoattractant, directing immune cells to sites of infection and inflammation, phage-stimulated IL-8 production may modulate some host immune responses. MDPI 2023-08-12 /pmc/articles/PMC10458410/ /pubmed/37632068 http://dx.doi.org/10.3390/v15081726 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Roach, Dwayne R.
Noël, Benoît
Chollet-Martin, Sylvie
de Jode, Mathieu
Granger, Vanessa
Debarbieux, Laurent
de Chaisemartin, Luc
Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
title Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
title_full Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
title_fullStr Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
title_full_unstemmed Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
title_short Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
title_sort human neutrophil response to pseudomonas bacteriophage pak_p1, a therapeutic candidate
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458410/
https://www.ncbi.nlm.nih.gov/pubmed/37632068
http://dx.doi.org/10.3390/v15081726
work_keys_str_mv AT roachdwayner humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate
AT noelbenoit humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate
AT cholletmartinsylvie humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate
AT dejodemathieu humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate
AT grangervanessa humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate
AT debarbieuxlaurent humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate
AT dechaisemartinluc humanneutrophilresponsetopseudomonasbacteriophagepakp1atherapeuticcandidate